Navigation Links
CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
Date:4/1/2008

LAS VEGAS, April 1, 2008 /PRNewswire-FirstCall/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBT) has appointed Nabil Dib, M.D., M.Sc., F.A.C.C., as the Principal Investigator for its Phase II clinical trial in patients with severe coronary heart disease.

Dr. Dib is currently the Director of Cardiovascular Research at Catholic Healthcare West's Chandler Regional Medical Center and Mercy Gilbert Medical Center in Arizona, as well as the Assistant Professor of Medicine and Director of Clinical Cardiovascular Cell Therapy at the University of California, San Diego. He is also President of the International Society for Cardiovascular Translational Research, La Jolla, Calif., and an international expert on the treatment of heart failure and coronary artery disease. Dr. Dib has extensive experience directing clinical trials, particularly in the arena of examining agents which stimulate the growth of new blood vessels in a damaged heart.

In previous clinical studies, Dr. Dib has pioneered the use of the NOGA(R) XP mapping system and the MyoStar(TM) injection catheter. These two devices will be used in CVBT's Phase II heart trial, in which the potent angiogenic protein human Fibroblast Growth Factor -1 (FGF-1) will be injected into patients' hearts. Dr. Dib serves as the principal trainer for all interventional cardiologists who wish to receive training on the NOGA XP system or MyoStar injection catheter, and will work closely with the other clinical investigators in CVBT's Phase II heart trial to ensure the safe and accurate injection of FGF-1 into the heart.

"We are extremely excited to welcome a cardiologist and clinical researcher of Dr. Dib's caliber to lead our Phase II heart study," said Thomas J. Stegmann, M.D., co-founder and co-president of CVBT. "His expertise with the NOGA XP and MyoStar devices, and his strong relationships with leading interventional cardiologists throughout the world will be invaluable to our clini
'/>"/>

SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Curemark Appoints Preeminent Pediatrics Gastroenterologist
2. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
3. West Pharmaceutical Services, Inc. Appoints New Director
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
6. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
7. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Lakeland Industries, Inc. (NASDAQ: LAKE ), a ... and to first responders on the federal, state and ... fiscal 2013 fourth quarter and year ended January 31, ... close and will conduct a conference call on the ... http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call will ...
(Date:5/17/2013)... May 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... holder and 130um sorting chip.  Sony will also be exhibiting ... new SH800 Cell Sorter, the EC800 flow cytometer, and new ... CYTO 2013, which will be held at the ... Diego, California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will ... Ken Berger , CEO, and Ed Borkowski ... ET live via telephone. To participate in the conference ... 366-0267. To participate in the conference call outside the U.S. ... The conference ID is 72195398. Participants should dial in 10 ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... (Soligenix or the Company) (OTC Bulletin Board: ... its President and Chief Executive Officer Christopher J. Schaber, ... at the Rodman & Renshaw 12th Annual Healthcare Conference ... on Wednesday, September 15, 2010 at 10:00AM EDT in ...
... Calif., Sept. 10 Sutter Health today announced a donation ... Red Cross to aid in relief efforts following a destructive ... and shelter. The donation is made on behalf of the ... addition to $50,000 generously donated by Sutter-affiliated California Pacific Medical ...
Cached Medicine Technology:Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT 2Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT 3Sutter Health Network Donates $150,000 to Aid Victims of San Bruno Fire 2
(Date:5/18/2013)... 18 (HealthDay News) -- Just a few extra cups ... of an autoimmune liver disease known as primary sclerosing ... the Mayo Clinic in Rochester, Minn., found that drinking ... the disease, which can lead to cirrhosis of the ... does not prove a cause-and-effect relationship. "While ...
(Date:5/18/2013)... are significant cost and risk factors associated with ... gastrointestinal problems, according to research presented at Digestive ... New York Presbyterian Hospital and Weill-Cornell Medical College ... the cost and risk of managing gastroesophageal reflux ... nearly 25 percent of adults, researchers found that ...
(Date:5/18/2013)... May 18, 2013 Assisted living ... comes to safety and comfort of their residents. ... provides clients with an effective and cost-efficient solution ... is an integrated, turnkey communications solution that helps ... allowing residents independence and privacy. , The ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 ... mesh products continue to move forward in a consolidated ... Bernstein Liebhard LLP reports. According to a notice on ... the Ethicon pelvic mesh litigation will be held on ... complaints have been filed in the proceeding on behalf ...
(Date:5/18/2013)... May 18, 2013 The “World Healthcare ... and studies the major market drivers, restraints, and opportunities ... world. , Browse , 89 ... in-depth TOC on "Healthcare IT Market" , ... customization on reports. , The global healthcare IT market ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3
... the growing shift toward oral chemotherapy agents offers cancer patients ... of the new medications also poses more chances for patients ... in a dangerous way. An increasing number of cancer patients ... click of a pill bottle each day rather than the ...
... 28 Niutang Chemical , one ... in the world, today announced it plans to ... 300 metric tons, within the next three years. ... its sucralose capacity to 1,000 metric tons by 2014.(Logo: ...
... PerformLOS ANGELES, May 28 The Pediatric Inflammatory Bowel ... Producer Alexandra Milchan-Lambert and Relativity Media President of Production ... 2009 at Culver Studios. The afternoon will celebrate ... and will feature a fun-filled day of activities including ...
... WASHINGTON, May 28 The State of Florida took ... children yesterday when Governor Charlie Crist signed a $1 ... legislature through the budget dramatically increased funding for smoking ... toll-free QuitLine (877-U-CAN-NOW).Florida,s cigarette tax had been the fourth ...
... A new statewide poll of registered voters finds ... to give the U.S. Food and Drug Administration (FDA) the ... expected to debate this issue next week, and Senators Webb ... Congress will finally pass this life-saving legislation.(Logo: ...
... many potential new drug targets for cancers long deemed ... contain. These studies are beginning to reveal new ways ... of normal genes that cancer cells rely on for ... Medical Institute (HHMI) investigators D. Gary Gilliland of Brigham ...
Cached Medicine News:Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 2Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 3Health News:Niutang to Expand Sucralose Capacity 66 Percent by 2012 2Health News:The Pediatric IBD Center at Cedars-Sinai Medical Center Presents Rock-n-Reel 2009 Honoring Alexandra Milchan-Lambert & Scott Lambert 2Health News:Florida's $1 Cigarette Tax Increase a Big Win for Public Health 2Health News:Florida's $1 Cigarette Tax Increase a Big Win for Public Health 3Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 2Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 3Health News:The vulnerable cancer cell 2Health News:The vulnerable cancer cell 3Health News:The vulnerable cancer cell 4Health News:The vulnerable cancer cell 5Health News:The vulnerable cancer cell 6
Toxo IgG ELISA. All Wampole ELISA kits include the following: 12 x 8 well strips with breakaway wells, sample diluent, controls and calibrators, conjugate, TMB substrate, wash buffer, stop solution,...
Herpes Simplex Virus 2 IgG ELISA....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
Medicine Products: